Sector RS Rank Nov 11: Chips Lead, Natural Gas Fall
Contents
💡 Today’s US market in three lines
① Today’s three stocks: Edwards Lifesciences · Jazz Pharmaceuticals · Alkermes
② What rose today: semiconductors, AI tech, blockchain
③ What pulled back: natural gas, junior gold miners, silver miners
Today’s Sector Relative Strength (RS)

- Chip stocks came back hard on Wednesday. CoreWeave jumped +24.71% after its quarterly report, and the AI trade followed. The S&P 500 rose +1.31% to 7,619.38. The Nasdaq gained +1.60% to 25,466.19, and the Dow added +0.49% to 52,486.49, about 255 points. Micron climbed +11.89% and AMD +7.32%. Nvidia recovered +2.87% after two losing days. The bond market was closed for Veterans Day. Gold futures slipped -0.98% to $3,990.80, and WTI crude edged up +0.40% to $86.38. The VIX fell to 17.49 from 19.46.


- Of the 129 ETFs in our universe, 106 closed higher, 22 fell, and one was flat. Ten of the 11 sectors rose. Technology (XLK) led at +3.23%, with energy (XLE) next at +1.86%. Consumer discretionary (XLY) was the only decliner at -0.05%. The equal-weight S&P 500 (RSP) gained +0.80%. Big tech did most of the lifting.
Today’s Leading Sectors TOP 5
| ETF | 1-Day | RS Rank 1M | Short-Term | Mid-Term | Long-Term |
|---|---|---|---|---|---|
| iShares U.S. Medical Devices (IHI) | +0.17% | 99 | ▲ rising | ▲ rising | ▲ rising |
| Global X Aging Population (AGNG) | +0.22% | 99 | ▲ rising | ▲ rising | ▲ rising |
| Health Care Select Sector SPDR (XLV) | +0.04% | 98 | ▲ rising | ▲ rising | ▲ rising |
| iShares U.S. Pharmaceuticals (IHE) | +0.56% | 97 | ▲ rising | ▲ rising | ▲ rising |
| VanEck Pharmaceutical (PPH) | +0.10% | 96 | ▲ rising | ▲ rising | ▲ rising |
- The same five funds held the top spots. Medical devices (IHI) rose from 97 to 99 and now ties aging population (AGNG). U.S. pharma (IHE) moved from 96 to 97. Pharma (PPH) slipped from 99 to 96 and ties consumer staples (XLP), which has a smaller one-month gain. Health care still fills all five spots, even on a day when chips stole the headlines.
Why They’re Strong — Sector Issues

· Semiconductors (SOXX) — Up +6.01%, sheet RS rank 7. Micron rose +11.89%, Entegris +11.29%, and MACOM +10.32%. CoreWeave’s report eased worries about AI spending. The fund is still down -14.29% over one month.


· Future AI (ARTY) — Up +5.86%, sheet RS rank 13. CoreWeave gained +24.71%, Seagate +9.99%, and Super Micro +9.50%. Storage and server makers rose along with the chips. The fund sits back above its 200-day average.


· Blockchain (BKCH) — Up +5.28%, sheet RS rank 2. Galaxy Digital rose +13.18%, Core Scientific +10.97%, and Canaan +10.31%. Bitcoin added only +1.06%. Several of these miners also lease power to AI data centers, so they traded with the AI group.


· Meme Stocks (MEME) — Up +9.67%, sheet RS rank 0. It was the best fund of the day. It is still down -22.29% over one month.
What Changed From Yesterday
- Space infrastructure (ORBX) posted the biggest one-day rank gain, 44 to 58. Pharma (XPH) went from 84 to 95, and data centers (DTCR) from 31 to 43. In all three, a weak day from October 13 leaving the window helped as much as Wednesday’s prices. Biotech (XBI) also climbed, but almost entirely for that reason.


- Natural gas (UNG) lost the most, 49 to 18, on a -1.92% day. About two thirds of that drop came from a strong day a month ago leaving the window. Oil explorers (IEO) fell from 29 to 19 even though they rose +2.59%, for the same reason. Tuesday’s report said health care had all five leading spots. That held on Wednesday.
1-Month RS Trend

- Blockchain (BKCH) fell from 97 to 2 over the window, and future AI (ARTY) from 85 to 13. Semiconductors (SOXX) went from 40 to 6 after peaking at 100. Natural gas (UNG) slid from 83 to 18 after touching 100. Junior gold miners (GDXJ) dropped from 88 to 41. One strong day has not changed these lines yet.
RS Breakdown Warnings

- E-commerce (EBIZ) dropped from 84 to 64, the only valid breakdown. Six other funds were dropped because Wednesday’s price moved the other way or stayed flat, including energy (XLE) and oil (USO).
RS Rebound Signals

- Space infrastructure (ORBX) jumped from 9 to 58, the strongest rebound. Space (UFO) rose from 26 to 71, humanoid robotics (HUMN) from 35 to 68, and space and deep sea (ROKT) from 40 to 65. Twelve funds passed the check in all. Space and robotics now make up most of the list.
Today’s Top Rising Sectors TOP 5 (by 1-day %)
| ETF | 1-Day | RS Rank 1M | Short-Term | Mid-Term | Long-Term |
|---|---|---|---|---|---|
| Roundhill Meme Stocks (MEME) | +9.67% | 0 | ▼ falling | ▼ falling | ▼ falling |
| iShares Semiconductor (SOXX) | +6.01% | 7 | ▼ falling | ▼ falling | ▼ falling |
| Global X AI Semiconductor and Quantum (CHPX) | +5.94% | 8 | ▼ falling | ▼ falling | ▼ falling |
| iShares Future AI and Tech (ARTY) | +5.86% | 13 | ▼ falling | ▼ falling | ▲ rising |
| Global X Blockchain (BKCH) | +5.28% | 2 | ▼ falling | ▼ falling | ▼ falling |
Why They Rose
- All five rank 13 or lower and sit below their 20-day and 50-day averages. It was a bounce in the weakest corner. Leadership did not change. On the other side, natural gas (UNG) -1.92%, junior gold miners (GDXJ) -1.68%, silver miners (SIL) -1.52%, and gold miners (GDX) -1.48% fell the most as gold eased.
Leading Sectors: Medical Devices, Aging Population, Health Care
- ① Medical devices (IHI) rose from 97 to 99. It gained +0.17% and stays above every average.
- ② Aging population (AGNG) held at 99 on a +0.22% day.
- ③ Health care (XLV) stayed at 98. It was nearly flat at +0.04% while the S&P 500 rose.
- ④ The last report covered the November 10 close. Its three picks from that close to Wednesday’s: Palomar -1.20%, Assurant +0.38%, and Viatris +1.01%, against +1.31% for the S&P 500. None beat the index. All three stayed above the levels the report flagged: Palomar at $159.15, Assurant at $323.38, and Viatris at $21.06. Recorded as is.
Today’s Three Stocks — Edwards Lifesciences · Jazz Pharmaceuticals · Alkermes Stock Forecast
- Thirty-one stocks passed the four-part filter. These three fit the day’s leaders: medical devices and pharma.
Edwards Lifesciences (EW) — Heart Valve Maker Stock Forecast

| Stock | RS 1D | RS 5D | RS 1M | 1M Return | Held By |
|---|---|---|---|---|---|
| Edwards Lifesciences (EW) | 70 | 87 | 95 | +24.1% | iShares U.S. Medical Devices 4.8% · Global X Aging Population 3.5% |
- Closed at $105.81, +1.73%, its highest close in a year. Edwards makes replacement heart valves delivered by catheter. Third-quarter sales rose +10.5% to $1.72 billion. Adjusted EPS rose +19% to $0.80. GAAP EPS was $0.53 after a $220.2 million impairment charge. Mitral and tricuspid sales jumped +44% to $207 million. Edwards raised its 2026 sales growth outlook to about 11.5%, its third raise this year. The Edwards Lifesciences stock forecast rests on whether that newer valve line keeps growing this fast.
Jazz Pharmaceuticals (JAZZ) — Sleep and Cancer Drugmaker Stock Forecast

| Stock | RS 1D | RS 5D | RS 1M | 1M Return | Held By |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals (JAZZ) | 61 | 86 | 88 | +18.0% | iShares U.S. Pharmaceuticals 3.2% · SPDR S&P Pharmaceuticals 2.0% · VanEck Pharmaceutical 1.2% |
- Closed at $248.24, +1.14%. Jazz sells sleep disorder and cancer drugs. Third-quarter revenue rose to $1.24 billion from $1.13 billion. Sleep drug Xywav grew +12% to $483 million, and oncology sales rose +35%. The quarter ended in a loss because of a $754 million charge tied to its Actio purchase. Jazz raised its 2026 revenue guidance to $4.775 billion to $4.85 billion. The Jazz Pharmaceuticals stock forecast depends on oncology carrying more of the growth.
Alkermes (ALKS) — Neuroscience Drugmaker Stock Forecast

| Stock | RS 1D | RS 5D | RS 1M | 1M Return | Held By |
|---|---|---|---|---|---|
| Alkermes (ALKS) | 83 | 82 | 92 | +20.5% | SPDR S&P Biotech 1.5% |
- Closed at $47.89, +3.06%. Alkermes sells treatments for addiction, schizophrenia, and sleep disorders. It reported on November 3. Third-quarter revenue rose +22% to $480.1 million. Narcolepsy drug Lumryz added $89.9 million in its first full quarter after the Avadel purchase. Net income fell to $16.3 million from $82.8 million on $29.8 million of deal costs. Management kept its 2026 revenue guidance of $1.73 billion to $1.84 billion. The Alkermes stock forecast leans on how fast Lumryz grows.
Edwards Lifesciences · Jazz Pharmaceuticals · Alkermes Stock Forecast Checkpoints
· Edwards Lifesciences stock forecast — It rose +6.5% in five sessions to a one-year high. Watch whether it holds above $99.37, the November 4 close.
· Jazz Pharmaceuticals stock forecast — It sits well above its 20-day average of $220.35. Watch whether it holds above $234.66, the November 4 close.
· Alkermes stock forecast — Wednesday’s close was its best since August. Watch whether it stays above $46.47, Tuesday’s close.
What to Watch on Next Week’s Calendar
- October PPI, Friday, November 13, 8:30 a.m. ET
- Tuesday’s CPI came in hot. The bond market reopens on Thursday, so Friday’s producer price print will be the next test for yields. Home construction (ITB), down -0.77% on Wednesday, remains the leader most exposed to rates.
- October retail sales, Tuesday, November 17, 8:30 a.m. ET
- Consumer discretionary (XLY) was the only sector that fell on Wednesday. Retail (XRT) still ranks 95. The report will show whether shoppers support that rank.
- 🔴 Nvidia third-quarter results, Tuesday, November 17, 4:00 p.m. ET, after the close
- Semiconductors (SOXX) bounced +6.01% but still rank 7. Nvidia’s report will show whether Wednesday’s rally can turn into a lasting recovery.
- 🔴 Anthropic IPO pricing, Wednesday, November 18, with trading expected November 19
- The prospectus has drawn attention to chip suppliers, and Micron rose +11.89% on Wednesday. A listing this large could also pull money from other AI names.


